| 2261261. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase HY Cohen, C Miller, KJ Bitterman, NR Wall, B Hekking, B Kessler, ... Science 305 (5682), 390-392, 2004 | 2421 | 2004 |
| Cancer gene therapy using a survivin mutant adenovirus M Mesri, NR Wall, J Li, RW Kim, DC Altieri The Journal of clinical investigation 108 (7), 981-990, 2001 | 637 | 2001 |
| Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis T Dohi, E Beltrami, NR Wall, J Plescia, DC Altieri The Journal of clinical investigation 114 (8), 1117-1127, 2004 | 588 | 2004 |
| Yin Yang 1 is a negative regulator of p53 G Sui, EB Affar, Y Shi, C Brignone, NR Wall, P Yin, M Donohoe, MP Luke, ... Cell 117 (7), 859-872, 2004 | 475 | 2004 |
| Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function P Fortugno, NR Wall, A Giodini, DS O'Connor, J Plescia, KM Padgett, ... Journal of cell science 115 (3), 575-585, 2002 | 470 | 2002 |
| Regulation of microtubule stability and mitotic progression by survivin A Giodini, MJ Kallio, NR Wall, GJ Gorbsky, S Tognin, PC Marchisio, ... Cancer research 62 (9), 2462-2467, 2002 | 445 | 2002 |
| A p34cdc2 survival checkpoint in cancer DS O'Connor, NR Wall, ACG Porter, DC Altieri Cancer cell 2 (1), 43-54, 2002 | 443 | 2002 |
| Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis NR Wall, DS O’Connor, J Plescia, Y Pommier, DC Altieri Cancer research 63 (1), 230-235, 2003 | 378 | 2003 |
| Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer S Khan, JMS Jutzy, MMA Valenzuela, D Turay, JR Aspe, A Ashok, ... Public Library of Science 7 (10), e46737, 2012 | 363 | 2012 |
| Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis OP Blanc-Brude, M Mesri, NR Wall, J Plescia, T Dohi, DC Altieri Clinical Cancer Research 9 (7), 2683-2692, 2003 | 349 | 2003 |
| Survivin is released from cancer cells via exosomes S Khan, JMS Jutzy, JR Aspe, DW McGregor, JW Neidigh, NR Wall Apoptosis 16, 1-12, 2011 | 308 | 2011 |
| Small RNA: can RNA interference be exploited for therapy? NR Wall, Y Shi The Lancet 362 (9393), 1401-1403, 2003 | 302 | 2003 |
| Internalization of exosomes through receptor-mediated endocytosis A Gonda, J Kabagwira, GN Senthil, NR Wall Molecular Cancer Research 17 (2), 337-347, 2019 | 242 | 2019 |
| Early diagnostic value of survivin and its alternative splice variants in breast cancer S Khan, HF Bennit, D Turay, M Perez, S Mirshahidi, Y Yuan, NR Wall BMC cancer 14, 1-10, 2014 | 231 | 2014 |
| Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential S Khan, JR Aspe, MG Asumen, F Almaguel, O Odumosu, ... British journal of cancer 100 (7), 1073-1086, 2009 | 193 | 2009 |
| Making meaningful clinical use of biomarkers MJ Selleck, M Senthil, NR Wall Biomarker insights 12, 1177271917715236, 2017 | 191 | 2017 |
| Genistein‐induced G2‐m arrest, P21WAF1 upregulation, and apoptosis in a non‐small‐cell lung cancer cell line F Lian, M Bhuiyan, YW Li, N Wall, M Kraut, FH Sarkar Taylor & Francis Group 31 (3), 184-191, 1998 | 187 | 1998 |
| Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin’s lymphoma and chronic lymphocytic leukemia ML Varterasian, RM Mohammad, MS Shurafa, K Hulburd, PA Pemberton, ... Clinical Cancer Research 6 (3), 825-828, 2000 | 139 | 2000 |
| Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75 M Mediavilla-Varela, FJ Pacheco, F Almaguel, J Perez, E Sahakian, ... Molecular cancer 8, 1-15, 2009 | 133 | 2009 |
| Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant JR Aspe, CJ Diaz Osterman, JMS Jutzy, S Deshields, S Whang, NR Wall Journal of extracellular vesicles 3 (1), 23244, 2014 | 127 | 2014 |
